Workshop report: A study roadmap to evaluate the safety of recombinant human lactoferrin expressed in Komagataella phaffii intended as an ingredient in conventional foods – Recommendations of a scientific expert panel-Reference-Cited by-同舟云学术

Workshop report: A study roadmap to evaluate the safety of recombinant human lactoferrin expressed in Komagataella phaffii intended as an ingredient in conventional foods – Recommendations of a scientific expert panel

Published:2024-08 Issue: Volume:190 Page:114817
ISSN:0278-6915
Container-title:Food and Chemical Toxicology
language:en
Short-container-title:Food and Chemical Toxicology

Author:

Malinczak Carrie-Anne^ORCID,Burns Naas Leigh Ann^ORCID,Clark Anthony,Conze Dietrich,DiNovi Michael,Kaminski Norbert,Kruger Claire,Lönnerdal Bo^ORCID,Lukacs Nicholas W.,Merker Robert^ORCID,Peterson Ross^ORCID

Publisher

Elsevier BV

Reference83 articles.

1. Sub-chronic (13-week) oral toxicity study in rats with recombinant human lactoferrin produced in the milk of transgenic cows;Appel;Food Chem. Toxicol.,2006

2. Managing the impact of immunogenicity in an era of immunotherapy: from bench to bedside;Bray-French;J. Pharmaceut. Sci.,2021

3. INFOGEST static in vitro simulation of gastrointestinal food digestion;Brodkorb;Nat. Protoc.,2019

4. Regulatory framework for substances intended for use in human food or animal food on the basis of the generally recognized as safe (GRAS) provision of the federal food, drug, and cosmetic act: guidance for industry,2017

5. 28-day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats;Cerven;Regul. Toxicol. Pharmacol.,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-week GLP immunotoxicity assessment of lactoferrin alpha produced byKomagataella phaffiiin Sprague Dawley rats;2024-08-19

2. Evaluation of the potential food allergy risks of human lactoferrin expressed in Komagataella phaffii;Frontiers in Immunology;2024-07-24

3. A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults;2024-07-17